Europe’s Oncology Community Meets at ECCP 2010 in Oslo September 15-17

Building on Toulouse's success, European Cancer Cluster Partnering Conference again attracts unique mix of oncology biotechs, pharma, investors and other stakeholders.

OSLO--(BUSINESS WIRE)-- Europe’s most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.

Partnering is the overall theme. The two opening sessions will focus on Oncology 2020 and give an outlook for the decade ahead and discuss new models for collaboration between academia and industry to drive innovation. Building on that, a roundtable will discuss how a “global bioscience gateway” involving partners from the US, Europe and China can accelerate the development of new cancer diagnostics and medicines.

In addition, meeting sessions will address important aspects of oncology including the role of biomarkers in personalised medicine, the need for cancer-focussed clinical trial networks and ways to adapt to the financing/partnering climate.

Bjarte Reve, CEO of the Oslo Cancer Cluster aims to build on the success of last year’s inaugural conference which attracted some 263 companies from 23 countries: “Treatment and survival rates for cancer continue to improve and we believe ECCP provides the perfect forum for the oncology community to meet and find ways to further accelerate the development and uptake of new diagnostics and treatments.”

NOTES TO EDITORS

ECCP – European Cancer Cluster Partnering

The first ECCP conference was held in Toulouse, France in September 2009. It was a great success and 365 participants from 22 countries, presenting 263 companies, attended. 550 one-to-one meetings were arranged using the ECCP partnering platform and a similar number of meetings were spontaneously set up on the site. A large portion of partnering meetings resulted in follow-up activities and over 100 potential business deals were made according to the evaluation survey.

ECCP 2010 conference is organized by Oslo Cancer Cluster (Oslo, Norway) and the Cancer–Bio - Santẻ Cluster (Toulouse, France). The meeting is dedicated to oncology companies focusing on diagnostics, therapeutics, drug delivery, imaging and medical devices.

Find the programme at www.ECCP2010.com



CONTACT:

Schwartz Communications
Richard Hayhurst
Tel +44 (0) 7711821527
Email: [email protected]

KEYWORDS:   Europe  Norway  France

INDUSTRY KEYWORDS:   Health  Biotechnology  Medical Devices  Oncology  Pharmaceutical  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

Bayer has struck a $425 million upfront deal to buy KaNDy in the belief its treatment for menopause-related hot flashes has blockbuster potential.

After its recent $4.8 billion buyout of gene therapy specialist Spark Therapeutics, Roche is now handing over one of its execs as its CMO.

LianBio aims to bring much-needed new drugs to China and serve as a partner for U.S. biotechs looking to expand into Asia.